Literature DB >> 10207093

Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein.

K Liu1, L Li, P E Nisson, C Gruber, J Jessee, S N Cohen.   

Abstract

Random homozygous knockout (RHKO) is an antisense RNA strategy capable of identifying genes whose homozygous functional inactivation yields a selectable phenotype in cells growing in culture. Using this approach, we isolated NIH 3T3 fibroblast clones that showed the ability to form colonies on 0.5% agar and tumors in nude mice. The gene inactivated in one of these clones was found to encode VASP (vasodilator-stimulated phosphoprotein), a previously identified protein that binds to components of the cadherin-catenin junctional complex and has been implicated in cell-cell interactions, the formation of actin filaments, and the transmission of signals at the cytoskeleton-membrane interface. Fibroblasts made deficient in VASP by RHKO showed loss of contact inhibition, and consequently, continued cell division past confluence. Restoration of VASP function by reversal of RHKO yielded cells that had lost the neoplastic capabilities acquired during RHKO. Overproduction of VASP mRNA in the sense or antisense orientation from expression constructs introduced by transfection into naive NIH 3T3 fibroblasts also resulted in neoplastic transformation, implying that normal cell growth may require the maintenance of VASP expression within a narrow range. Our results implicate VASP in tumorigenesis and/or cancer progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207093      PMCID: PMC84183          DOI: 10.1128/MCB.19.5.3696

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control.

Authors:  A Gualberto; K Aldape; K Kozakiewicz; T D Tlsty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 2.  The cytoskeleton in cancer cells.

Authors:  A Ben-Ze'ev
Journal:  Biochim Biophys Acta       Date:  1985

Review 3.  Tensin: a potential link between the cytoskeleton and signal transduction.

Authors:  S H Lo; E Weisberg; L B Chen
Journal:  Bioessays       Date:  1994-11       Impact factor: 4.345

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.

Authors:  E Butt; K Abel; M Krieger; D Palm; V Hoppe; J Hoppe; U Walter
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

6.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

7.  The focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to the proline-rich domain in vinculin.

Authors:  N P Brindle; M R Holt; J E Davies; C J Price; D R Critchley
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

9.  Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.

Authors:  L Li; S N Cohen
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

Review 10.  Integrins, oncogenes, and anchorage independence.

Authors:  M A Schwartz
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

View more
  10 in total

1.  Regulation of VASP by phosphorylation: consequences for cell migration.

Authors:  Heike Döppler; Peter Storz
Journal:  Cell Adh Migr       Date:  2013-12-05       Impact factor: 3.405

2.  Differential expression of VASP in normal lung tissue and lung adenocarcinomas.

Authors:  L Dertsiz; G Ozbilim; Y Kayisli; G A Gokhan; A Demircan; U A Kayisli
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

3.  Promotion of PDGF-induced endothelial cell migration by phosphorylated VASP depends on PKA anchoring via AKAP.

Authors:  Deling Zhang; Jingping Ouyang; Nian Wang; Yahui Zhang; Jinghua Bie; Yemin Zhang
Journal:  Mol Cell Biochem       Date:  2009-08-27       Impact factor: 3.396

4.  Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells.

Authors:  Lihua Chen; Günter Daum; Kanchan Chitaley; Scott A Coats; Daniel F Bowen-Pope; Martin Eigenthaler; Naresh R Thumati; Ulrich Walter; Alexander W Clowes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

5.  A functional mouse retroposed gene Rps23r1 reduces Alzheimer's beta-amyloid levels and tau phosphorylation.

Authors:  Yun-wu Zhang; Shijie Liu; Xue Zhang; Wu-Bo Li; Yaomin Chen; Xiumei Huang; Liangwu Sun; Wenjie Luo; William J Netzer; Richard Threadgill; Gordon Wiegand; Ruishan Wang; Stanley N Cohen; Paul Greengard; Francesca-Fang Liao; Limin Li; Huaxi Xu
Journal:  Neuron       Date:  2009-11-12       Impact factor: 17.173

Review 6.  Regulation of Cancer Cell Behavior by the Small GTPase Rab13.

Authors:  Maria S Ioannou; Peter S McPherson
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

7.  Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer.

Authors:  Ke Su; Pengchao Hu; Xiaolan Wang; Changchun Kuang; Qingmin Xiang; Fang Yang; Jin Xiang; Shan Zhu; Lei Wei; Jingwei Zhang
Journal:  Oncotarget       Date:  2016-07-19

8.  The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.

Authors:  Heike Döppler; Ligia Bastea; Sahra Borges; Xochiquetzal Geiger; Peter Storz
Journal:  Oncotarget       Date:  2015-10-06

9.  Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.

Authors:  Yihao Tian; Liu Xu; Yanqi He; Xiaolong Xu; Kai Li; Yanbin Ma; Yang Gao; Defei Wei; Lei Wei
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

10.  CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer.

Authors:  Peng-Chao Hu; Kai Li; Yi-Hao Tian; Wen-Ting Pan; Ying Wang; Xiao-Long Xu; Yan-Qi He; Yang Gao; Lei Wei; Jing-Wei Zhang
Journal:  Int J Biol Sci       Date:  2019-10-21       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.